China approves two domestically developed Covid drugs
BEIJING: China has approved two domestically developed oral medicines for Covid-19 patients with mild symptoms, the National Medical Products Administration said on Sunday.The drugs, used for treating adult patients with mild to moderate Covid-19 infections, have been developed by Simcere Pharmaceutical Group and a unit of Shanghai Junshi Biosciences Co Ltd, the administration said in […]